Myeloperoxidase -463G > A polymorphism and risk of primary lung cancer in a Korean population

Cancer Detection and Prevention

Volumn 30, Issue 3, 2006, Pages 257-261

  Park, Jae Hyung ^a   Park, Jung Min ^b   Kim, Eun Jin ^a   Cha, Sung Ick ^a   Lee, Eung Bae ^a   Kim, Chang Ho ^a   Kam, Sin ^b   Jung, Tae Hoon ^a   Yong Park, Jae ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Lung cancer; Myeloperoxidase; Polymorphism; Pulmonary carcinogenesis; Risk estimate; Smoking history; Susceptibility; Tobacco smoke; Tumor histology

Indexed keywords

MYELOPEROXIDASE;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENDER; GENE; GENETIC POLYMORPHISM; GENOTYPE; HISTOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PEROXIDASE; POLYMORPHISM, GENETIC; RISK;

EID: 33746774191     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.04.002     Document Type: Article

References (22)

1. Mallet W.G., Mosebrook D.R., and Trush M.A. Activation of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidases. Carcinogenesis 12 3 (1991) 521-524
2. Reynolds W.F., Chang E., Douer D., Ball E.D., and Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute myelocytic leumkemia. Blood 90 7 (1997) 2730-2737
3. Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfahl M., and Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 271 24 (1996) 14412-14420
4. Van Schooten F.J., Boots A.W., Knaapen A.M., Godschalk R.W., Maas L.M., Borm P.J., et al. Myeloperoxidase (MPO) -463G → A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomark Prev 13 5 (2004) 828-833
5. Feyler A., Voho A., Bouchardy C., Kuokkanen K., Dayer P., Hirvonen A., et al. Myeloperoxidase -463 G → A polymorphism and lung cancer risk. Cancer Epidemiol Biomark Prev 11 12 (2002) 1550-1554
6. Xu L.L., Liu G., Miller D.P., Zhou W., Lynch T.J., Wain J.C., et al. The myeloperoxidase -463 G → A polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomark Prev 11 12 (2002) 1555-1559
7. Dally H., Gassner K., Jager B., Schmezer P., Spiegelhalder B., Edler L., et al. Myeloperoxidase (MPO) genotype and lung cancer histologic types: The MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers. Int J Cancer 102 5 (2002) 530-535
8. Kiyohara C., Yoshimasu K., Takayama K., and Nakanishi Y. NQQ1, MPO, and the risk of lung cancer: a huge review. Genet Med 7 7 (2005) 463-478
9. Le Marchand L., Seifried A., Lum A., and Wilkens L.R. Association of the myeloperoxidase -463 G → A polymorphism with lung cancer risk. Cancer Epidemiol Biomark Prev 9 2 (2000) 181-184
10. Lu W., Xing D., Qi J., Tan W., Miao X., and Lin D. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population. Int J Cancer 102 3 (2002) 275-279
11. Lee S.J., Jeon H.-S., Jang J.S., Park S.H., Lee G.Y., Lee B.H., et al. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26 2 (2005) 403-409
12. Lee G.Y., Jang J.S., Lee S.Y., Jeon H.-S., Kim K.M., Choi J.E., et al. XPC polymorphisms and lung cancer risk. Int J Cancer 115 5 (2005) 807-813
13. Lee S.J., Lee S.Y., Jeon H.-S., Park S.H., Jang J.S., Lee G.Y., et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomark Prev 14 3 (2005) 571-575
14. Lee C.T., Kang K.H., Koh Y., Chang J., Chung H.S., Park S.K., et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer 30 1 (2000) 15-22
15. London S.J., Lehman T.A., and Taylor J.A. Myeloperoxidase genetic polymorphism and lung cancer. Cancer Res 57 22 (1997) 5001-5003
16. Katsuda N., Hamajima N., Tamakoshi A., Wakai K., Matsuo K., Saito T., et al. Helicobacter pylori seropositivity and the myeloperoxidase G-463A polymorphism in combination with interleukin-1B C-31T in Japanese health checkup examinees. Jpn J Clin Oncol 33 4 (2003) 192-197
17. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., et al. Association of genetic polymorphisms in CYP2E1, MPO, NQQ1, GSTM1, and GSTT1 genes with benzene poisoning. Environ Health Perspect 110 12 (2002) 1213-1218
18. Misra R.R., Tangrea J.A., Virtamo J., Ratnasinghe D., Andersen M.R., Barrett M., et al. Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett 164 2 (2001) 161-167
19. Chevrier I., Stucker I., Houllier A.M., Cenee S., Beaune P., Laurent-Puig P., et al. Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenetics 13 12 (2003) 729-739
20. Cascorbi I., Henning S., Brockmoller J., Gephart J., Meisel C., Muller J.M., et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res 60 3 (2000) 644-649
21. Schabath M.B., Spitz M.R., Hong W.K., Delclos G.L., Reynolds W.F., Gunn G.B., et al. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer 37 1 (2002) 35-40
22. Hamajima N., Matsuo K., Suzuki T., Nakamura T., Matsuura A., Tajima K., et al. Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn J Cancer Res 92 5 (2001) 488-493